Lifevantage PE Ratio 2010-2023 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of April 18, 2024 is 13.88.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-19 6.70 29.13
2023-12-31 5.97 $0.23 25.95
2023-09-30 6.38 $0.20 31.91
2023-06-30 4.04 $0.20 20.20
2023-03-31 3.31 $-0.06 0.00
2022-12-31 3.40 $-0.05 0.00
2022-09-30 3.40 $0.04 85.08
2022-06-30 3.92 $0.24 16.33
2022-03-31 4.26 $0.70 6.08
2021-12-31 5.65 $0.73 7.74
2021-09-30 6.05 $0.98 6.18
2021-06-30 6.57 $0.90 7.30
2021-03-31 8.36 $0.81 10.32
2020-12-31 8.33 $0.80 10.42
2020-09-30 10.79 $0.84 12.85
2020-06-30 12.09 $0.79 15.30
2020-03-31 9.21 $0.79 11.66
2019-12-31 13.96 $0.80 17.44
2019-09-30 12.25 $0.56 21.87
2019-06-30 11.60 $0.50 23.21
2019-03-31 12.78 $0.45 28.39
2018-12-31 11.79 $0.45 26.20
2018-09-30 9.82 $0.41 23.96
2018-06-30 5.69 $0.41 13.89
2018-03-31 3.23 $0.21 15.37
2017-12-31 4.26 $0.09 47.28
2017-09-30 3.77 $0.09 41.92
2017-06-30 3.87 $0.11 35.19
2017-03-31 4.80 $0.26 18.46
2016-12-31 7.29 $0.33 22.08
2016-09-30 8.46 $0.42 20.14
2016-06-30 12.16 $0.42 28.95
2016-03-31 8.14 $0.26 31.29
2015-12-31 8.51 $0.26 32.73
2015-09-30 5.07 $0.22 23.04
2015-06-30 3.32 $0.49 6.77
2015-03-31 4.94 $0.63 7.85
2014-12-31 8.14 $0.70 11.62
2014-09-30 7.13 $0.84 8.49
2014-06-30 9.01 $0.70 12.88
2014-03-31 8.20 $0.56 14.64
2013-12-31 10.33 $0.63 16.40
2013-09-30 14.89 $0.42 35.48
2013-06-30 14.52 $0.42 34.58
2013-03-31 14.71 $0.70 21.01
2012-12-31 13.70 $0.14 97.89
2012-09-30 21.46 $0.49 43.81
2012-06-30 17.71 $0.42 42.17
2012-03-31 23.53 $-3.78 0.00
2011-12-31 8.95 $-4.34 0.00
2011-09-30 9.39 $-4.27 0.00
2011-06-30 9.39 $-4.34 0.00
2011-03-31 4.44 $-0.98 0.00
2010-12-31 2.44 $-1.05 0.00
2010-09-30 3.13 $-1.54 0.00
2010-06-30 3.19 $-1.47 0.00
2010-03-31 2.44 $-1.68 0.00
2009-12-31 1.56 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.086B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.176B 18.25
Becton Dickinson (BDX) United States $67.358B 19.56
West Pharmaceutical Services (WST) United States $27.623B 46.70
Cardinal Health (CAH) United States $25.783B 15.50
Align Technology (ALGN) United States $22.677B 45.73
Cooper (COO) United States $17.970B 27.19
Labcorp (LH) United States $16.779B 14.33
Henry Schein (HSIC) United States $8.990B 15.55
DENTSPLY SIRONA (XRAY) United States $6.312B 16.63
Merit Medical Systems (MMSI) United States $4.122B 23.58
STAAR Surgical (STAA) United States $2.285B 71.95
Patterson (PDCO) United States $2.282B 10.93
CONMED (CNMD) United States $2.189B 20.60
Atrion (ATRI) United States $0.679B 34.97
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00